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Abstract
Biomimetic nanomaterials have attracted tremendous research interest in the past decade. We 
recently developed biomimetic core-shell nanoparticles – silica nanocapsules, using a designer 
dual-functional peptide SurSi under room temperature, neutral pH and without use of any toxic 
reagents or chemicals. The SurSi peptide is designed capable of not only stabilizing 
nanoemulsions because of its excellent surface activity, but also inducing the formation of 
silica through biosilicification at an oil-water interface. However, it remains challenging to 
precisely control the peptide-induced nucleation and biosilicification specifically at the oil-
water interface, thus forming oil-core silica-shell nanocapsules with uniform size and 
monodispersity. In this study, the fundamental mechanism of silica formation through a peptide 
catalyzed biosilicification was systematically investigated, so that the formation of oil-core 
silica-shell nanocapsules can be precisely controlled. The SurSi peptide induced hydrolysis and 
nucleation of biomineralized silica particles were monitored to study the biosilicification 
kinetics. Effects of pH, SurSi peptide concentration and pre-hydrolysis of silica precursors 
were also studied to optimize the formation of biomimetic silica nanocapsules. The 
fundamental understanding achieved through these systematic studies provides valuable 
insights for making core-shell nanoparticles via controlling nucleation and reaction at 
interfaces.
Introduction
Core-shell nanoparticles are attractive as the core can be loaded with drug or image agents, and 
the shell provides a barrier protecting the loaded active components as well as makes it easier 
for different surface modification [1]. The choice of material for the core and shell affect greatly 
their final applications [2]. Depending on the selection of the shell materials, methods for 
making core-shell nanoparticles are diverse [2, 3], such as precipitation [4-6], polymerization 
[7-10], microemulsion[11-13], sol-gel condensation [14, 15], and layer by layer adsorption 
techniques [16, 17]. 
Silica is an attractive shell material. It provides many advantages including good 
biocompatibility and degradability, good dispersity, and easy to functionalize [18, 19]. 
Traditional methods for making silica core-shell materials are mainly based on the sol-gel 
method that often requires toxic chemicals or solvents, high temperature or extreme pH to 
remove the core, which could result in toxic residues in the final materials, inconsistent shell 
structure or rupture of the shell because of the harsh conditions used for core removal. In 
contrast, biomimetic mineralization has attracted significant interests in making various kind 
of inorganic nanomaterials such as silica, titania [20], calcium phosphate [19], metal organic 
frameworks (MOFs) [21, 22] owning to its benign synthesis conditions.
We developed a novel and green biomimetic technology to form core-shell materials using 
dual-functional peptides [23-29]. These biomolecules have a unique two-module design, one 
module for surface activity to make stable droplets, and the other one for biosilisification 
activity. Briefly, oil-in-water emulsions are formed by dispersing oil in an aqueous solution 
containing the dual-module peptide. Because of the excellent surface activity of this peptide, 
monodisperse emulsions can be formed with the peptide adsorbing at the interface [30]. Then 
a silica precursor (e.g., tetraethyl orthosilicate, TEOS) is added to the emulsion to initiate the 
biosilicification at the oil-water interface at room temperature, neutral pH, and without toxic 
chemicals or reagents. After mixing, silica nanocapsules are generated with a well-controlled 
core-shell structure. The core size, which depends on the droplet size, can be tuned by using 
different homogenization energy input, different concentrations of peptide or different volume 
ratio of the oil phase, while the shell thickness can be controlled by adjusting the reaction time 
and the precursor concentration[25]. This bioinspired method is simple, sustainable, 
biocompatible, and doesn’t involve any extreme conditions or toxic chemicals. It offers a 
unique strategy for making functional core-shell materials for various applications [1]. 
However, the mechanism underlying the silica hydrolysis, nucleation, growth mediated by the 
biomolecule remains unclear. 
In this study, we systematically investigate the hydrolysis, nucleation and growth of silica, the 
composition of the silica nanoparticles based on biosilicification using a peptide, as well as the 
effect of pH, pre-hydrolysis on the formation of core-shell nanoparticles. This study provides 
a comprehensive understanding of the biomolecule directed silica formation at oil-water 
interfaces.
Experimental
Materials. Materials. Peptide SurSi (Ac-MKQLAHSVSRLEHA RKKRKKRKKRKKGGGY-
CONH2) was synthesized by Mimotopes Pty Ltd. (Australia) with a purity ≥95%. Water having 
resistivity >18.2 MΩ·cm was obtained from a Milli-Q system (Millipore, Australia) equipped 
with a 0.22 μm filter. Tetraethoxysilane (TEOS), zinc chloride (ZnCl2), ammonia, and 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) were of analytical grade purchased 
from Sigma-Aldrich and used as received unless otherwise stated.
Silica nanoparticle formation by biosilicification. Silica nanoparticles were synthesized 
based on a biosilicification method using a designer peptide SurSi. Tetraethoxysilane (TEOS, 
10, 40 or 80 mM) and SurSi (200 μM) were mixed in 25 mM HEPES buffer at pH 7.5 under 
350 rpm magnetic stirring at room temperature (25 °C). The reaction was monitored over a 
period of 42 hours. Dynamic Light Scattering (DLS) was used to monitor the reaction. At 
different time points of 11, 14, 16, 17, 18, 19, 20, 21, 24, 27, 30, 33, 36, 39, and 42 h, the 
sample was analyzed using DLS (size, polydispersity index, derived count rates and zeta 
potential). To study the effect of TEOS concentration on silica nanoparticle morphology, 5 µL 
sample was taken for Transmission Electron Microscopy (TEM) observation at 18, 24, 36 and 
42 h. To study the effect of pH on biosilication, HEPES buffer with pH ranging from 6.5 to 8.5 
(HEPES buffer range: pH=6.8 to 8.2) was prepared for reaction, and 5 µL sample was collected 
for TEM observation at 18, 24 and 40 h.
Silica nanoparticles formation by Stöber method. Silica particles were also prepared by the 
Stӧber method [31]. 2.39 mL ethanol, 106.5 µL ammonium hydroxide and 325.7 µL water 
were mixed under 500 rpm magnetic stirring at room temperature for 45 min, then 175.4 µL 
TEOS was added and reacted for another 80 min.
Trifluoroacetic acid (TFA) removal. SurSi peptide was dissolved in Milli-Q water and then 
dialysis with 3.5 kDa cutoff Snakeskin membrane (Thermo Fisher Scientific)  in 1L Milli-Q 
water at 4 ºC overnight to remove TFA. Then SurSi without TFA was lyophilized and 
quantified using High Performance Liquid Chromatography (HPLC) for biosilicification.
Silica nanocapsule synthesis using SurSi. To make nanoemulsions, SurSi peptide was 
dissolved in HEPES buffer (25 mM, pH 7) to prepare a peptide solution of 400 μM, followed 
by adding 800 μM ZnCl2. Miglyol 812 oil (2% v/v) was added to the peptide solutions. For 3 
mL emulsion, 60 µL Miglyol 812 oil was added into 2940 µL peptide solution. The peptide 
solution was sonicated using a Sonifier 450 ultrasonicator (Branson Ultrasonics, Danbury, CT) 
for 30 seconds five times with 1 min cooling between each sonication. The nanoemulsion was 
dialysed using 10 kDa cutoff Snakeskin membrane (Thermo Fisher Scientific) in 25 mM, 
pH=7.5 HEPES buffer at 4 ºC for certain time (5-20 h). Silica precursor tetraethoxysilane 
(TEOS) was added and reacted with nanoemulsion  at room temperature. Nanocapsules were 
dialysed in 25 mM pH=7.5 HEPES buffer at 4 ºC for 16 h to remove residual peptide and stop 
the reaction. To investigate the effect of pre-hydrolysis on silica capsules formation, silica 
precursor was hydrolyzed in 500 µL of 200 µM SurSi solution for 6 and 10 hours, then mixed 
with 500 µL emulsion to make silica nanocapsules.
Interfacial tension. Interfacial tension was measured by a Drop shape analysis DSA-10 
method (Krüss GmbH, Germany). To measure interfacial tension kinetics, a quartz cuvette 
(Hellma GmbH, Germany) was filled with a peptide solution sample (8 mL) of SurSi in HEPES 
buffer (25 mM, pH 11). A Miglyol 812 oil droplet was formed in the peptide solution through 
an inverted stainless-steel needle with a diameter of 1.507 mm connected to a glass syringe. 
The instrument was calibrated by forming a pure oil droplet (Miglyol 812) in HEPES buffer 
without peptide, confirming a constant interfacial tension of approximately 30 mN/m. The 
interfacial tension was measured automatically over 600 s after the initial formation of an oil 
droplet.
Characterizations
Dynamic Light Scattering (DLS). The size, polydispersity index (PdI) and zeta potential of the 
silica nanoparticles were measured by Malvern Zetasizer Nano ZS (Malvern Instruments, 
Malvern, UK). The scattering angle of measurement was 173° and the measurement was set at 
room temperature 25 °C. 
Transmission Electron Microscopy (TEM). The morphologies of silica nanoparticles were 
imaged by Hitachi HT7700 transmission electron microscopy (Hitachi, Tokyo, Japan) under 
100 kV voltage. To prepare the TEM samples, 5 µL silica nanoparticle solution was pipetted 
from the bulk solution and dropped onto a formvar-coated copper grid. After 5 min drying, 
extra liquid was absorbed by Kimtech wipes (Kimberly Clark, Irving, Texas, US).
Fourier-transform infrared (FTIR). The surface chemical structure was determined by Fourier-
transform infrared (FTIR) spectroscopy. Nanoparticles were lyophilized into dry powder and 
analysed by using a Nicolet™ iS50 FTIR Spectrometer (Thermo Fisher Scientific, Waltham, 
MA). 
Thermogravimetric analysis (TGA). The peptide content in silica particles were determined by 
thermogravimetric analysis (TGA) using a STARe thermogravimetric analyzer (Mettler-
Toledo, LLC, Columbus, OH). Particles were washed three times with water to remove residual 
chemicals and peptide, then lyophilized for TGA analysis. Samples were heated from 40 to 950 
°C at a rate of 10 °C min-1.
Data analysis. All the experiments were performed in triplicate and repeated three times, and 
average of the results were used to make the plots or tables.
Results
Formation of bioinspired silica nanocapsules
The biomimetic approach for making oil-core silica-shell nanocapsules is a simple emulsion-
templated biosilicification method using a bifunctional peptide SurSi (Ac-
MKQLAHSVSRLEHA RKKRKKRKKRKKGGGY-CONH2). Fig. 1 shows the process for 
synthesizing silica nanocapsules. Typically, the SurSi peptide is dissolved in a HEPES buffer 
to make a peptide solution, and 2% v/v Miglyol 812 oil is added to the peptide solution, 
followed by sonication to make nanoemulsions. Then, the nanoemulsion is dialyzed to reduce 
the free peptide in the bulk solution to avoid the formation of silica particles in the bulk 
solution. A silica precursor is then added to the nanoemulsion to initiate the reaction. After 
reacting for a certain period of time under stirring, the suspension is dialyzed to remove residual 
silicic acid and stop the reaction, and silica nanocapsules are synthesized. Although it is a 
simple and facile process, the precise control of biosilicification specifically at oil-water 
interface rather than in bulk solution thus forming uniform oil-core silica-shell nanoparticles is 
not trivial. Therefore, it is important to fundamentally understand the peptide-mediated 
nucleation and growth of silica in the presence of oil-water nanoemulsions.
Fig. 1. Schematic of emulsion-templated silica nanocapsule formation.
Effect of silica precursor concentration on nucleation and growth of silica nanoparticles
To investigate the peptide catalyzed nucleation and growth of silica via the sol-gel process, 200 
µM SurSi was mixed with TEOS of different concentrations (10, 40 and 80 mM), and the 
reaction was monitored using DLS, including particle size, polydispersity index (PDI), derived 
count rate (DCR) and zeta potential (Fig. 2). The peptide catalyzed biosilicification started with 
the hydrolysis of TEOS, so no particle was detected in the first 15 hours (Fig. 2a). Then the 
sudden increase of particle size and PDI at 16-20 h for 40 and 80 mM TEOS indicated a sol-
to-gel transition forming three-dimensional siloxane network [32]. For a very low 
concentration of 10 mM TEOS, it didn’t show the dramatic size increase until 21 h  due to the 
low concentration of hydrolyzed silicic acid, as nucleation only occurs after the hydrolysed 
silicic acid concentration reaches the critical homogenous nucleation concentration [33]. For 
higher TEOS concentrations (40 and 80 mM), it took another 6-7 hours for the particle size to 
stabilize at around 100 nm to 150 nm, whereas this condensation process was much longer 
(around 14 hours) for 10 mM TEOS. Also, it was obvious that the resultant silica nanoparticle 
size decreased with TEOS concentration. After 36 hour reaction, the silica nanoparticle sizes 
were 107.4 nm, 124.1 nm and 136.8 nm for 10 mM, 40 mM and 80 mM TEOS, respectively.
Fig. 2b shows the polydispersity index (PDI) results reflecting the dispersity of particles 
suspension. Similar to the particle size result, there was a big jump at around 18 h for 40 and 
80 mM TEOS and 24 h for 10 mM TEOS, indicating the formation of irregular three-
dimensional siloxane network. Then when silica nanoparticles started to form, the PDI 
decreased and remained stable at around 0.2 (for 10 and 40 mM TEOS) indicating the formation 
of uniform silica nanoparticles. It was also observed that higher TEOS concentration led to 
quicker particle growth, resulting in higher chance of aggregation. As a result, the 80 mM 
TEOS generated nanoparticles with slightly higher PDI (~0.3) than those using 10 and 40 mM 
TEOS. 
Derived count rate (DCR) is the count rate divided by the attenuation factor, which has a 
positive correlation with the particle number in the solution. Nucleation results in rapid and 
distinct growth in particle number where DCR increases rapidly. As shown in Fig. 2c, the DCR 
increased significantly between 18 hours to 21 hours for 40 and 80 mM TEOS indicating the 
start of nucleation. After initial nucleation at 18 h, the particles number kept growing until 36 
h and remained constant at 36-42 h, which is consistent with the result of particle size (Fig. 
2a). This indicates that nucleation occurs mainly during 18-36 h, followed by particle growth 
at 36-42 h.  Fig. 2c also shows the effect of TEOS concentration on nucleation and particle 
growth. Higher TEOS concentrations (40 mM and 80 mM) generated higher nucleation rate 
and more particles in the solution compared to lower TEOS concentration (10 mM). Similar to 
the size and PDI results, the DCR increase of 10 mM TEOS was also delayed about 9 hours, 
and the final DCR number was much lower than those of the 40 and 80 mM TEOS reactions.
Fig. 2d shows the surface charge of the particles. Nuclei formed at the beginning with slightly 
negative charges. But when silica nanoparticles started to form, their zeta potential increased 
significantly to +15-20 mV suggesting the adsorption of positively charged peptide SurSi on 
the negatively charged silanol groups, which is in contrast to silica formation using chemical 
methods. Then after peptides were consumed, the zeta potential of silica particles decreased 
and the particles start to aggregate. Consequently, the PDI of the particles started to grow after 
40 hours, and big aggregation formed with even longer reaction time (e.g. 50 hours). Again, 
the zeta potential change of silica nanoparticles using 10 mM TEOS occurred much later (at 
around 40 h).
Fig. 2. Dynamic Light Scattering results of nucleation and particle growth during SurSi 
peptide induced biosilicification (TEOS reacted with 200 µM SurSi in 25 mM pH 7.5 HEPES 
buffer). a, Silica nanoparticles size in diameter; b, PDI; c, Derived count rate; d, Zeta potential. 
These DLS results depict the peptide catalyzed nucleation and growth of silica via a sol-gel 
process. The concentration of silica precursor TEOS affected significantly the hydrolysis and 
condensation of TEOS, consequently the nucleation and growth of silica with a big delay for a 
low TEOS concentration (10 mM), while there was not much difference between 40 amd 80 
mM TEOS. For these two higher concentrations, an induction time of about 15 hours was 
observed suggesting the hydrolysis of TEOS and formation of a sol solution. Then the sol 
solution was converted to a gel with a three-dimensional network accompanied by a sudden 
size jump. Then after 6-7 h polymerization and condensation, uniform silica nanoparticles were 
generated. While further prolonging the reaction resulted in bigger particle size and slightly 
increased PDI. Surprisingly, these peptide-induced silica nanoparticles had positive charges 
indicating the incorporation of positively charged SurSi peptide.
Silica particle morphology was observed using TEM (Fig. 3), showing the formation of a few 
irregular nuclei at 18 h. Then many small particles with size ranging from 20 nm to 50 nm were 
observed at 24 h. Higher silica precursor concentration resulted in higher nucleation rate so 
produced more and bigger particles. With longer reaction time, silica nanoparticles became 
denser and larger. At 42 h, many particles with sizes around 100 nm were formed with spherical 
shape. The concentration of TEOS didn’t have much effect on the final silica particle size.
Fig. 3. TEM image of TEOS silica particles.  10 mM, 40 mM, 80 mM TEOS reacted with 
200 µM SurSi in 25 mM pH 7.5 HEPES buffer from 18 h to 42 h, the scale bars are 200 nm.
Effect of SurSi peptides on silica nanoparticles
As mentioned above, the SurSi-induced silica nanoparticles showed distinct charge from 
traditional silica nanoparticles. To determine the role of the SurSi peptide in biosilicification 
and the amount of peptides contained in the nanoparticles, silica nanoparticles prepared by 
biosilicification were compared to those synthesized using the Stöber method. Although the 
Stöber method produced silica nanoparticles (Table 1) with a similar size (149.4 nm) as those 
silica nanoparticles by biosilicification (145.1 nm), their surface charges were distinct. The 
Stöber silica nanoparticles was negative, while the bioinspired silica was positively charged 
indicating the presence of the SurSi peptide in the particle. As shown in Fig.4, both bioinspired 
silica nanoparticles and Stöber silica nanoparticles were amorphous, but the Stöber silica 
nanoparticles have a more smooth surface than the bioinspired silica (Fig. 4b, 4d).
To further confirm the presence of SurSi in the bioinspired silica nanoparticles, FTIR study 
was conducted for both the Stöber silica and bioinspired silica. Fig. 5a shows that both Stöber 
silica and bioinspired silica had the peak around 1650  which corresponds to the signal cm ―1
of the N-H bond from either arginine (R) and lysine (K) in the peptides or the ammonium 
hydroxide used in the Stöber method. After washing, most of ammonium was removed, so N-
H bonding in bioinspired silica was much stronger. Biomimetic silica also showed a very strong 
peak at 1540 cm-1 (corresponding to C-H bending) suggesting again the presence of SurSi 
peptide in the biomimetic silica nanoparticles.
Table 1. DLS results for silica nanoparticles prepared by biosilicification method and Stöber 
method.
Sample Size (d.nm) PDI Zeta potential (mV)
Bioinspired silica nanoparticles 145±1 0.28±0.01 18.7±0.8
Stöber silica nanoparticles 150±1 0.06±0.01 -40.2±0.5
Fig. 4. TEM image of silica particles. a, b. Biomimetic silica nanoparticles (40 mM TEOS 
reacted with 200 µM SurSi in 25 mM pH 7.5 HEPES buffer from 42 h), c, d. Stöber silica 
nanoparticles. The scale bars are 200 nm.
To quantify the amount of peptide in the silica nanoparticles, thermal gravimetric analysis 
(TGA) was conducted using the Stöber silica particles as the reference. As shown in the Fig. 
5b silica particles kept losing weight with the increasing of temperature. The weight loss at 
around 100 ºC was water residual that was not removed through lyophilisation. After 100 ºC, 
the Stöber silica nanoparticles lost weight slowly mainly from the further condensation of 
hydroxyl group under high temperature. For bioinspired silica nanoparticles, from 100 ºC to 
500 ºC, the weight loss of the silica nanoparticles was not only from condensation of hydroxyl 
group but also from the burned peptide, which were around 18 % (Table 2). In contrast, the 
Stöber silica nanoparticles had 7.1% weight loss and the SurSi peptide lost 80% weight from 
100 – 500°C. The residual 12% weight of the SurSi peptide was mainly from salts contained 
in the sample. The significant weight loss of the bioinspired silica nanoparticles (18%) in 
contrast to that of the Stöber silica (7.1%) confirmed the presence of SurSi peptide in the 
particles.
Fig. 5. Fourier-transform infrared spectroscopy spectrum (a) and TGA results (b) of the 
silica nanoparticles formed by biosilicification and the Stöber method. Orange: silica 
particles prepared by biosilicification method; Cyan: silica particles prepared by the Stöber 
method; Purple: SurSi peptide.
Table 2 Percentage of weight loss versus temperature
Percentage of weight loss %Sample
25-100°C 100-500°C 500-800°
Stöber silica 3.6 7.1 1.4
Biosilificiation silica 4.8 18.1 4.7
SurSi peptide 2.2 80.3 5.1
Effect of trifluoroacetic acid (TFA) on peptide activity
TFA or TFA salt often presents in the commercial peptide product. Thus, it is important to 
investigate whether TFA affects the peptide activity during biosilicification. In biosilicification, 
both the surface activity from Sur module and the ability to induce silica formation from Si 
mudule are important, so two questions need to be answered (i) whether TFA affects the surface 
activity of SurSi; (ii) whether TFA affects silica formation. To address the first question, the 
interfacial tension of Miglyol 812 oil in SurSi peptide solution with and without TFA were 
measured at pH=11 (Fig. 6). Both SurSi with and without TFA had strong surface activity, but 
SurSi with TFA showed a slightly lower interfacial tension of 6.04 mN/m. As TFA is slightly 
surface active, it can adsorb on interface which could affect silica shell formation. As shown 
in Fig. 7, the silica shell formed by SurSi with TFA was thinner than that from SurSi without 
TFA. The silica shell thickness formed without TFA was around 25 nm in average, and the 
shell was more even. In contrast, the silica shell synthesized using SurSi with TFA were only 
20 nm for the thickest part, and for the thinnest area, the shell thickness was less than 8 nm, 
which makes the shell prone to break. Therefore, it is very important to remove TFA from the 
peptide sample.
Fig. 6 Effect of TFA on peptide surface activity. a. Interfacial tension of Miglyol 812 in 
black: Milli-Q water, Red: SurSi peptide dialysed for 16 hours to remove TFA, SurSi 
concentration was 200 µM, Blue: SurSi peptide with TFA, SurSi concentration was 200 µM, 
TFA content was 43.5% according to the synthesis report, TFA concentration was 4.9 mM. 
The pH of three solutions were adjusted to 11 by NaOH; b: Equilibrium interfacial tension. 
Fig. 7 TEM image for TEOS silica nanocapsules: a. 200 µM SurSi peptide without TFA b. 200 
µM SurSi with 4.9 mM TFA. Reaction was carried out in 25 mM HEPES buffer (pH=7.5) for 
30 hours. The scale bars are 200 nm.
Effect of pH and peptide concentration on biosilicification
In order to investigate the effect of pH on biosilicification, silica particle formation was 
monitored under different pH (from 6.5 to 8.5). The chemical reactions during the sol-gel 
process can be described by the following three equations:
                       Hydrolysis                                  (1)≡ Si ― OR + H2O → ≡ Si ― OH + ROH
                Condensation                              (2)≡ Si ― OH + Si ― OR → ≡ Si ― O ― Si ≡ +ROH
           Condensation                              (3)≡ Si ― OH + ≡ Si ― OH → ≡ Si ― O ― Si ≡ + H2O
pH as the catalyst affects the reaction mechanisms for acid or base catalysis very differently. 
The minimum rate for hydrolysis is at pH 7, for condensation at pH 4.5 [34]. Therefore, either 
very low or very high pH in the presence of solvents (ethanol, methanol, etc.) is used for making 
silica particles. In contrast, we developed this SurSi-induced biosilicification approach under 
near neutral pH and without any solvents. But the pH effect on hydrolysis and condensation 
also applies for our biosilicification. In addition to the peptide SurSi, pH also acts as a catalyst, 
so when pH is reduced to below 7, the condensation is compromised, but pH above 7 not only 
increases the hydrolysis but also the condensation, and too high pH makes the reaction too 
rapid thus uncontrolled formation of silica. This agrees with what we observed in the 
experiments. As shown in Fig. 8, lower pH led to much slower reaction rate, so no particle was 
detected and observed. Higher pH gave much more rapid hydrolysis rate, and the peptide 
activity was also higher, which made the reaction very fast. At pH=8.0, large particles appeared 
within 18 hours, and after 40 hours huge aggregation was observed. Therefore pH 7.5 was 
selected for forming silica.
Fig.8 Effect of pH on biosilicification. Reaction time was 18, 24 and 40 hours and the pH 
ranged from 6.5 to 8.5. The scale bars are 200 nm.
The peptide concentration also plays an important role. Higher nucleation rate was observed 
when increasing the SurSi concentration from 100 to 400 µM resulting in smaller particles 
(Fig. 9). But high peptide concentration could also lead to the formation of silica particles in 
the bulk solution rather than on the oil-water interface to form silica nanocapsules. 
Fig.9 Effect of SurSi concentration on biosilicification. a. 100 µM; b. 200 µM and c. 400 µM. 
Reaction time was 24 hours. The scale bars are 200 nm.
The effect of SurSi concentration in the bulk solution on nanocapsule formation was 
investigated by dialyzing the emulsion for different time including 5, 10, 20, 22 h, and the 
residual SurSi concentrations in the bulk solution were 167, 146, 101 and 97 µM, respectively. 
We found that uniform nanocapsules were produced for 5-20 hours dialysis time, which 
corresponds to peptide concentrations around 100 – 167 µM (Fig. 10). Shorter dialysis time 
led to precipitation of silica nanoparticles in the bulk solution, while longer dialysis resulted in 
slower biosilicification and no formation of nanocapsules of good quality. 
Fig.10 Effect of dialysis time on nanocapsule formation. a: 5 h dialysis; b: 10 h dialysis; c: 20 
h dialysis. Reaction time was 30 h. The scale bars are 200 nm.
Effect of silica precursor pre-hydrolysis on silica capsules formation. To further study the 
mechanism of silica nanocapsules formation, whether the nanocapsule formation requires 
hydrolysing around the emulsion droplets, or silicic acid could hydrolyze first and then adsorb 
onto the emulsion droplets surface to form silica shell, pre-hydrolysis of the silica precursor 
TEOS was introduced to the experiment (Table 3). 40 mM TEOS was hydrolyzed in the 
presence of 200 µM SurSi for 6 or 10 hours, then the prehydrolyzed solution was mixed with 
the emulsion and reacted to make silica nanocapsules.  For both 6-hour and 10-hour pre-
hydrolyzed TEOS, silica nanocapsules still formed with similar size and good monodispersity 
(Fig. 10). However, 18-hour pre-hydrolysis resulted in the formation of big aggregates, because 
silica nuclei already formed after such a long hydrolysis time. Consequently, mixing of the 
positively charged emulsion and negatived charged silica nuclei led to instant aggregation. 
Table 3. Size and zeta potential for prehydrolysed silica capsules
Pre-hydrolysis time 
(hours)
Z-Ave (d.nm) PDI ZP (mV)
6 259±8 0.24±0.01 30±3
10 230±6 0.17±0.02 40±2
Fig. 11 Silica nanocapsule formation using pre-hydrolyzed TEOS. a. 6 hours prehydrolysis; b. 
10 hours prehydrolysis. The scale bars are 200 nm.
Mechanism of interface-peptide mediated silica nanocapsule formation
Based on the systematic study above on all the key factors affecting nanocapsule formation, 
we propose a mechanism for the interface-peptide mediated silica nanocapsule formation (Fig. 
11). Positively charged SurSi peptide adsorbs on the emulsion surface to stabilize the 
nanoemulsion. Upon the addition of a silica precursor TEOS, hydrolysis of TEOS starts. The 
concentration of hydrolyzed silicic acid and silicate oligomers increases with the 
concentrations of TEOS. When the concentration of silicate oligomers rises to the critical 
heterogamous nucleation concentration (C1), nucleation occurs at the peptide-covered oil-
water interface and large amount of oligomers are consumed (Fig. 11a). However, when the 
concentration of silicate oligomers is higher than a critical homogenous nucleation 
concentration in bulk solution (C2), silica nanoparticles start to form in bulk solution (Fig. 
11a). Until the oligomer concentration is below C1, homogeneous nucleation terminates while 
heterogeneous nucleation starts, thus leading to the formation of both silica nanoparticles and 
silica nanocapsules. Therefore, to avoid forming silica nanoparticles in bulk solution, the 
oligomer concentration needs to be below C2 but above C1 (Fig. 11a). A number of amino 
acids in SurSi play important roles in peptide-mediated biosilicification (Fig. 11b). Four amino 
acid residues including serine (S), tyrosine (Y), histidine (H) and glutamine (Q) are able to 
promote nucleophilic attack thus facilitating the hydrolysis of TEOS. Additionally, Serine (S) 
and tyrosine (Y) enhance the formation of hydrogen bonding with silanol while positively 
charged lysine (K) and arginine (R) interact with negative silanolate through electrostatic 
interaction or ion pairing. As a result, the concentrations of TEOS and SurSi should be within 
a proper range. Under such conditions, negatively charged silicate oligomers are attracted to 
the emulsion droplet surface by electrostatic interaction and condensed to form a layer of silica 
shell. Then more SurSi peptide adsorbs and induces more silica formation at the shell until 
SurSi or silicic acid is fully consumed (Fig. 11c), or the reaction is stopped by dialysis to 
remove residual SurSi and silicic acid in the bulk solution. The SurSi concentration in the bulk 
solution is critical, as high SurSi concentration promotes quick hydrolysis and condensation of 
TEOS and higher concentration of silicate oligomers, thus higher chance forming silica 
nanoparticles in the bulk solution. On the contrary, if the peptide concentration is too low, the 
biosilicification reaction occurs too slow. Therefore, the residual peptide concentration in the 
bulk solution should be controlled by tuning dialysis time. As demonstrated in our experiment, 
dialysis for 5-20 h is appropriate for forming uniform nanocapsules. After all the optimization 
experiments described above, the optimized conditions for forming silica nanocapsules using 
the SurSi peptide was obtained (400 µM SurSi to form nanoemulsion, 5-20 hours dialysis with 
pH=7.5 HEPES buffer, reacted with 40 mM TEOS). 
Fig. 12 Mechanism of interface-peptide mediated silica nanocapsule formation. (a) Schematic 
illustration of peptide/silicate oligomers concentration in the bulk solution at different reaction 
time in the presence of oil-water interfaces (emulsion droplets); b. Schematic illustration of 
interface-kinetics mediated nucleation and silica growth thus the formation of oil-core silica-
shell nanocapsules.
Conclusions
This study presents a fundamental study on the formation of core-shell silica nanocapsules 
using a dual-functional peptide SurSi, which is not only able to facilitate the formation of 
uniform nanoemulsions as a result of the surfactant module, but also induce biosilicification at 
oil-water interface forming silica shell because of its biosilicification activity. Several key 
factors affect the biosilicification at the oil-water interface thus forming uniform silica 
nanocapsules including silica precursor concentration, SurSi peptide concentration, and 
reaction pH. High silica precursor concentration, SurSi peptide and pH resulted in faster 
hydrolysis and biosilicification, thus forming uncontrolled silica formation in the bulk solution. 
Under optimized conditions (40 mM silica precursor TEOS, 400 µM SurSi, and pH 7.5), 
uniform silica nanocapsules of 150 nm were synthesized. SurSi peptide was found to play 
critical roles not only in the nucleation of silica at the oil-water interface but also the continuing 
growth of the silica shell. It took 18-20 hours for the hydrolysis of TEOS in the presence of 
SurSi peptide at pH 7.5 followed by nucleation and silica growth at the interface via a sol-gel 
process. Both the FTIR and TGA result confirmed that SurSi peptide was incorporated in the 
silica shell, thus resulting in a positive charge in contrast to the negatively charged silica formed 
using the traditional Stober method. Furthermore, to control the interface-peptide mediated 
biosilicification, SurSi concentration in the bulk solution is critical. Dialysis (5-20 h) is able to 
control SurSi concentration below the homogeneous nucleation in the bulk solution, but above 
the heterogeneous nucleation at the oil-water interface to form uniform silica nanocapsules. 
These fundamental understandings of the mechanism of interface peptide induced silica 
formation is essential to obtain oil-core silica-shell nanocapsules with well controlled 
properties. It also provides new insight into the design of new core-shell materials based on 
biomineralisation.
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